Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Vaccine

Where you can get the monkeypox vaccine in Greater Manchester next week

More clinics will run in the region over the next two weeks

Manchester Evening News

Commentary: You might need a COVID booster yearly. But this virus is still nothing like the flu

Should everyone eligible get the new omicron-specific COVID booster? Yes, absolutely. But we should not get lulled into the illusion that the fight against COVID is over and now comparable to preventing the flu.

Los Angeles Times

Commentary: Will vaccine fatigue affect how many people get the bivalent booster?

Pfizer’s and Moderna’s bivalent boosters, which are now available to many age groups, offer protection against the original COVID-19 virus plus the BA.4 and BA.5 omicron subvariants. Is the nation ready for yet another COVID-19 vaccine shot?

Chicago Tribune

From analysis to the latest developments in health,
read the most diverse news in one place.

Important Biotech Catalysts For September 15, 2022 - End Of The Day Summary

Pfizer (NYSE:PFE) announced positive top-line results from the pivotal Phase 3 trial assessing the safety, tolerability, and immunogenicity of its investigational pentavalent meningococcal vaccine (MenABCWY) in healthy individuals 10 through 25 years of age. The trial met all primary and secondary endpoints. Pfizer shares traded in a range of $45.7…

Benzinga

Queen Elizabeth II's death sparked a slew of misinformation. Here's what you need to know

Following the death of the Queen, rumours began to spread online on everything from the nature of her passing to the colour of the BBC's banner.

ABC News

Breakthrough malaria shot needs more funding

It took scientists 30 years to create the first malaria vaccine, approved by the World Health Organization in 2021. A second, even better one is now almost ready to be deployed against the disease. Governments and philanthropies should be stepping up their funding to global health partners so they can…

Bangkok Post

This 1 Stock Pays You Just for Owning It

Leading pharmaceutical company Pfizer (PFE) did exceptionally well during the pandemic thanks to the high demand for its COVID-19 vaccine, and it still has enough growth prospects. The company’s focus on strengthening its pipeline via business acquisitions, product development, and approvals is expected to deliver impressive growth in the upcoming…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Noah Feldman: A Texas judge just took religious ‘freedom’ too far

The long march of religious liberty exemptions is gaining speed. The people who brought you contraceptive care exemptions and COVID rule and vaccine exemptions have now moved on to insurance for anti-HIV drugs. Last week, a federal district court held that a Christian employer is entitled to an exemption from…

Tribune News Service

Nine Omicron symptoms affecting the fully vaccinated - and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

‘Stealthy’ new Covid variant can reinfect you every month

‘Even having had Omicron, we’re not well protected from further infections,’ said Prof Danny Altmann

The Independent UK

Pandemic fatigue threatens COVID-19, monkeypox funding requests

As the Biden administration asks Congress for additional federal dollars to fight infectious diseases, it faces a conundrum: pandemic fatigue.

Tribune News Service

Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary

The U.S. Food and Drug Administration (FDA) has granted fast track designation for the development of TRACON’s (NASDAQ:TCON) lead asset envafolimab (KN035) for patients with locally advanced, unresectable or metastatic undifferentiated pleomorphic sarcoma (UPS) and myxofibrosarcoma (MFS) who have progressed on one or two prior lines of chemotherapy. TRACON shares…

Benzinga

Malaria vaccine: the road has been long and tortuous, but we're getting there

A vaccine candidate, called R21, has been shown to be up to 80% effective at preventing malaria in young children, according to the latest trial results.

The Conversation

TikTok riddled with 'misleading information about Covid, Russia and climate change'

TikTik said it did 'not allow harmful misinformation, including medical misinformation, and we will remove it from the platform'

Wales Online

Get all your
news in one place.

100's of premium titles.
One news app.

Roll Call

Pandemic fatigue threatens COVID-19, monkeypox funding requests - Roll Call

COVID-19 hospitalizations and deaths are down, but White House argues that pandemic money is needed for future public health threats.

The Hindu

IISc scientists develop gold-coated vesicles to fight tuberculosis

The spherical vesicles, which can be delivered to immune cells, are expected to potentially trigger an immune response

Daily Mirror

Covid booster: How to book your autumn vaccine as infections begin to creep up

26 million people will be eligible for the coronavirus booster jab this winter, with the elderly and some frontline workers first in the queue to get protected.

Salon

Is the new omicron vaccine worth it?

The omicron-specific booster vaccine hit the market — some wonder if it's worth getting

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

TikTok search results riddled with misinformation: Report

A U.S. firm that monitors false online claims reports that searches for information about prominent news topics on TikTok are likely to turn up results riddled with misinformation

Bangkok Post

Hong Kong 'to tighten rules' for issuing provisional vaccine passes to travellers

HONG KONG: Health authorities will tighten rules on issuing travellers provisional vaccine passes to enter most premises in a bid to plug any loopholes in Hong Kong's policies to combat the coronavirus, the Post has learned.

Tribune News Service

Commentary: Did the US jump the gun with the new omicron-targeted vaccines?

Last month, the FDA authorized omicron-specific vaccines, accompanied by breathless science-by-press release and a media blitz. Just days after the FDA’s move, the Centers for Disease Control and Prevention followed, recommending updated boosters for anyone age 12 and up who had received at least two doses of the original COVID-19…

Bangkok Post

Singapore grants interim approval for Moderna's bivalent Covid booster vaccine

SINGAPORE: Singapore on Wednesday granted interim authorisation for a bivalent Covid-19 booster vaccine made by Moderna, the government said in a statement.

The Independent UK

As monkeypox drops in the West, still no vaccines for Africa

The outbreak of monkeypox is subsiding in Europe and parts of North America

ABC News

Japanese encephalitis vaccines expanded as one in 11 people tested show infection signs

As mosquito season approaches, health bodies along the NSW-Victoria border are racing to vaccinate people most at risk of contracting Japanese encephalitis virus.

The Guardian - UK

‘Unstoppable’ bird flu epidemic causes growing alarm among Dutch farmers

With millions of chickens and ducks culled so far, farmers say only a vaccine can save the poultry sector from the ‘invisible enemy’

1 … 215 216 217 218

People

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Centers for Disease Control and Prevention

328 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.